F. Amatore

917 total citations
30 papers, 384 citations indexed

About

F. Amatore is a scholar working on Dermatology, Immunology and Oncology. According to data from OpenAlex, F. Amatore has authored 30 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Dermatology, 13 papers in Immunology and 9 papers in Oncology. Recurrent topics in F. Amatore's work include Cutaneous lymphoproliferative disorders research (10 papers), Psoriasis: Treatment and Pathogenesis (7 papers) and CAR-T cell therapy research (5 papers). F. Amatore is often cited by papers focused on Cutaneous lymphoproliferative disorders research (10 papers), Psoriasis: Treatment and Pathogenesis (7 papers) and CAR-T cell therapy research (5 papers). F. Amatore collaborates with scholars based in France and United States. F. Amatore's co-authors include Laurent Gorvel, Daniel Olive, M. Viguier, A. Villani, B. Guillot, M. Tauber, Jean‐Jacques Grob, Nathalie Bonnet, Laëtitia Padovani and Anne Balossier and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of the Rheumatic Diseases.

In The Last Decade

F. Amatore

23 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Amatore France 8 240 162 108 51 41 30 384
Michael Conroy United States 9 186 0.8× 252 1.6× 27 0.3× 42 0.8× 85 2.1× 19 464
Sandra Garcês Portugal 8 302 1.3× 41 0.3× 41 0.4× 35 0.7× 63 1.5× 16 567
Anna K. Dewan United States 10 72 0.3× 309 1.9× 100 0.9× 115 2.3× 70 1.7× 24 496
Miguel Nogueira Portugal 9 212 0.9× 80 0.5× 109 1.0× 35 0.7× 40 1.0× 21 361
Caylib Durand Canada 9 158 0.7× 43 0.3× 20 0.2× 85 1.7× 79 1.9× 15 328
Andrés López Spain 8 125 0.5× 302 1.9× 111 1.0× 382 7.5× 25 0.6× 16 498
Amy Musiek United States 16 196 0.8× 141 0.9× 360 3.3× 179 3.5× 99 2.4× 60 569
Nicole L Byers United States 5 90 0.4× 91 0.6× 40 0.4× 37 0.7× 39 1.0× 5 377
Kathryn Ciccolini United States 10 46 0.2× 271 1.7× 134 1.2× 97 1.9× 63 1.5× 23 451
Krishan Thirunavukkarasu Australia 7 121 0.5× 78 0.5× 31 0.3× 42 0.8× 22 0.5× 9 430

Countries citing papers authored by F. Amatore

Since Specialization
Citations

This map shows the geographic impact of F. Amatore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Amatore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Amatore more than expected).

Fields of papers citing papers by F. Amatore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Amatore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Amatore. The network helps show where F. Amatore may publish in the future.

Co-authorship network of co-authors of F. Amatore

This figure shows the co-authorship network connecting the top 25 collaborators of F. Amatore. A scholar is included among the top collaborators of F. Amatore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Amatore. F. Amatore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amatore, F., Shaum Sridharan, Arivarasan Karunamurthy, et al.. (2024). Pathologic response rates to neoadjuvant pembrolizumab in locally advanced (LA) resectable cutaneous squamous cell carcinoma (cSCC).. Journal of Clinical Oncology. 42(16_suppl). 9591–9591. 5 indexed citations
2.
Wirth, Thomas, Marielle Martin, F. Amatore, et al.. (2024). POS0965 EXPLORING ANTIBODIES IN PSORIATIC ARTHRITIS: A NOVEL AUTOIMMUNE BIOMARKER DISCOVERED. Annals of the Rheumatic Diseases. 83. 700–700. 1 indexed citations
3.
Amatore, F., et al.. (2022). Occurrence of Sézary syndrome following the initiation of anti-IL-5 treatment. European Journal of Dermatology. 32(3). 419–420. 1 indexed citations
4.
5.
Amatore, F., Nicolás Ortonne, Marc Lopez, et al.. (2021). ICOS is widely expressed in cutaneous T-cell lymphoma and its targeting promotes potent killing of malignant cells. European Journal of Cancer. 156. S23–S24. 1 indexed citations
6.
Amatore, F., et al.. (2021). Occurrence of Sézary syndrome following the initiation of anti-IL-5 drug. European Journal of Cancer. 156. S41–S42.
7.
Amatore, F., et al.. (2021). Mogamulizumab in a patient with Sézary syndrome and severe atopic dermatitis. European Journal of Cancer. 156. S51–S52. 1 indexed citations
8.
Amatore, F., O. Dereure, E. Delaporte, C. Ram‐Wolff, & M. Bagot. (2021). Is mogamulizumab-induced alopecia areata associated with favorable outcomes in Sézary syndrome?. European Journal of Cancer. 156. S50–S51. 6 indexed citations
9.
Villani, A., F. Amatore, M. Tauber, et al.. (2020). Impact of the French guidelines on the prescribing habits of systemic treatments for moderate‐to‐severe psoriasis. Journal of the European Academy of Dermatology and Venereology. 34(11). e747–e748. 2 indexed citations
10.
Carron, Romain, Caroline Gaudy‐Marqueste, F. Amatore, et al.. (2020). Stereotactic radiosurgery combined with anti-PD1 for the management of melanoma brain metastases: A retrospective study of safety and efficacy. European Journal of Cancer. 135. 52–61. 24 indexed citations
11.
Amatore, F., Nicolás Ortonne, Marc Lopez, et al.. (2020). Effect of expression of ICOS in cutaneous T-cell lymphoma and its targeting on killing of malignant cells.. Journal of Clinical Oncology. 38(15_suppl). e20040–e20040. 2 indexed citations
12.
Amatore, F., Nicolás Ortonne, Marc Lopez, et al.. (2020). ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells. Blood Advances. 4(20). 5203–5214. 16 indexed citations
13.
Kaspi, Élise, et al.. (2020). A rare case of pleural localisation of both metastatic Merkel cell carcinoma and chronic lymphocytic leukaemia. Cytopathology. 32(3). 367–370. 2 indexed citations
14.
Villani, A., F. Amatore, M. Tauber, et al.. (2020). Impact des recommandations françaises sur les habitudes de prescription des traitements systémiques pour le psoriasis modéré à sévère. Annales de Dermatologie et de Vénéréologie. 147(12). A94–A95.
15.
Amatore, F., A. Villani, M. Tauber, M. Viguier, & B. Guillot. (2019). French guidelines on the use of systemic treatments for moderate‐to‐severe psoriasis in adults. Journal of the European Academy of Dermatology and Venereology. 33(3). 464–483. 126 indexed citations
16.
Amatore, F., A. Villani, M. Tauber, B. Guillot, & M. Viguier. (2019). Recommandations françaises sur l’utilisation des traitements systémiques chez les patients adultes atteints de psoriasis modéré à sévère. Annales de Dermatologie et de Vénéréologie. 146(6-7). 429–439. 12 indexed citations
17.
Amatore, F., Laurent Gorvel, & Daniel Olive. (2019). Role of Inducible Co-Stimulator (ICOS) in cancer immunotherapy. Expert Opinion on Biological Therapy. 20(2). 141–150. 76 indexed citations
18.
Frankel, Diane, Isabelle Nanni‐Metellus, Andrée Robaglia‐Schlupp, et al.. (2018). Detection of EGFR, KRAS and BRAF mutations in metastatic cells from cerebrospinal fluid. Clinical Chemistry and Laboratory Medicine (CCLM). 56(5). 748–753. 7 indexed citations
19.
Gaudy‐Marqueste, Caroline, Romain Carron, F. Amatore, et al.. (2017). Safety and results of anti-PD1 combined with radiosurgery for the treatment of melanoma brain metastases.. Journal of Clinical Oncology. 35(15_suppl). 9552–9552.
20.
Guis, Sandrine, P. Berbis, Delphine Stephan, et al.. (2016). TWEAK-binding autoantibodies are generated during psoriatic arthritis and are not influenced by anti-TNF therapy. Journal of Translational Medicine. 14(1). 185–185. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Conroy Breakdown of academic impact, for papers by Sandra Garcês Breakdown of academic impact, for papers by Anna K. Dewan Breakdown of academic impact, for papers by Miguel Nogueira Breakdown of academic impact, for papers by Caylib Durand Breakdown of academic impact, for papers by Andrés López Breakdown of academic impact, for papers by Amy Musiek Breakdown of academic impact, for papers by Nicole L Byers Breakdown of academic impact, for papers by Kathryn Ciccolini Breakdown of academic impact, for papers by Krishan Thirunavukkarasu
Rankless by CCL
2026